Related Experiment Video
Updated: Oct 16, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Outpatient antimicrobial stewardship programs in pediatric institutions in 2020: Status, needs, barriers
Rana E El Feghaly1,2, Elizabeth A Monsees1,2, Alaina Burns2,3
1Division of Infectious Diseases, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
Insights
Pediatric outpatient antimicrobial stewardship programs (ASP) lack dedicated time and funding, hindering antibiotic stewardship efforts. Increased administrative support and resources are crucial for developing sustainable outpatient ASP infrastructure.
Area of Science:
- Pediatric infectious diseases
- Antimicrobial stewardship
- Public health
Background:
- Pediatric outpatient antimicrobial stewardship programs (ASP) are critical for combating antibiotic resistance.
- Many institutions have robust inpatient ASPs but lack developed outpatient programs.
Purpose of the Study:
- To evaluate the current state of pediatric outpatient ASPs.
- To identify resources, interventions, and barriers in pediatric outpatient ASPs.
Main Methods:
- A cross-sectional study using an investigator-developed online survey.
- Survey deployed to leaders of institutions in the Sharing Antimicrobial Reports for Pediatric Stewardship OutPatient (SHARPS-OP) collaborative.
- Assessed institutional information, outpatient ASP status, interventions, and collaborative goals.
Main Results:
- Only 11% of participating institutions had dedicated financial support for outpatient ASPs, compared to 95.6% for inpatient ASPs.
- Common interventions included antimicrobial guidance, education, and quality improvement projects.
- Lack of time (91.1%) and financial support (53.3%) were the primary barriers to expanding outpatient ASPs.
Conclusions:
- Pediatric institutions significantly underinvest in outpatient ASPs compared to inpatient ASPs.
- Administrative leaders must provide dedicated time and financial support to build sustainable outpatient stewardship infrastructure.
- Collaborative efforts are needed to develop clear metrics and learning opportunities for pediatric outpatient ASP benchmarking.
Objective:
To assess current resources, interventions, and obstacles of pediatric outpatient antimicrobial stewardship programs (ASP).
Design:
Cross-sectional study.
Setting:
Institutions from the Sharing Antimicrobial Reports for Pediatric Stewardship OutPatient collaborative (SHARPS-OP).
Participants:
Antimicrobial stewardship leaders from the above institutions.
Methods:
An investigator-developed survey was deployed online in September 2020 to antimicrobial stewardship leaders in SHARPS-OP institutions. The survey was divided into 4 sections: (1) basic information, (2) status of pediatric outpatient ASP in the institutions including financial support, (3) outpatient ASP interventions undertaken by the institutions, and (4) needs and SHARPS-OP collaborative goals.
Results:
Of 56 invited institutions, 45 participated, achieving an 80% response rate. Only 5 sites (11%) had allocated financial support for an outpatient ASP, compared to 42 (95.6%) for their inpatient ASP. The most widely used outpatient ASP interventions included antimicrobial guidance (57.8%), education (46.7%), and quality improvement projects (37.8%). Time was identified as the biggest barrier to expanding outpatient ASPs (91.1%), followed by financial support (53.3%), development of meaningful reports (51.1%), and administrative support (44.4%). Important goals of the collaborative included seeking learning opportunities and developing clear metrics for pediatric outpatient ASP benchmarking. Program needs included securing operational support (35.8%) and strengthening data analysis (31.6%).
Conclusions:
Very few pediatric institutions with robust inpatient ASPs have devoted time and financial support to advance outpatient efforts. To promote appropriate antibiotic prescribing in the outpatient arena, time and resource funding by administrative leaders are necessary to develop a robust, sustainable stewardship infrastructure.
More Related Videos
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Antimicrobial Effectiveness
Pharmacokinetics in Pediatric Patients: Drug Distribution